StockNews.AI · 2 hours
TechPrecision posted FY2026 results with 300 bps gross margin expansion and improved EBITDA, driven by better project mix at Stadco and Ranor. Backlog stands at $52.1M funded with about $25M unfunded; 2027 guidance targets 10% revenue growth to $35–$37M and EBITDA of $3–$4M. If execution continues, TPCS could see margin improvement and cash-flow gains, though covenant-related liquidity risk remains.
Positive margin expansion and clear 2027 growth targets could rerate the stock, offset by covenant/liquidity risks and modest cash; near-term reaction likely favorable if results and call affirm guidance.
Bullish on a 1–3 quarter horizon as margin gains and guidance imply upside, but monitor covenant risk.
Earnings; reflects a small-cap defense/precision manufacturer delivering margin expansion and forward guidance. Fits earnings category given the detailed FY2026 results and 2027 outlook.